Trial Site Detail

 

Drug:
BEZ235 + MEK162
Trial:
Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients
Conditions: Solid Tumors
Trial Status:
Ongoing, but not recruiting

 

Carbone Cancer Center, University of Wisconsin

     
Madison , WI 53792
USA

 

Principal Investigator:
 Kari Wisinski
Contact:
 Jennifer Heideman 608-263-6222 phase1@medicine.wisc.edu
Activation Status of this Site:
 Closed
Notes about this Site:
Carbone Cancer Center, University of Wisconsin Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.